Media Summary: Together, we're redefining how the world detects and treats cancer. Today marks an important milestone — Volpara now operates ... Gleamer is expanding from its core focus in AI for musculoskeletal clinical applications into new clinical areas. We talked to ... Mosaic Clinical Technologies made its debut at as the AI division of
Rsna 2025 Interview With Lunit - Detailed Analysis & Overview
Together, we're redefining how the world detects and treats cancer. Today marks an important milestone — Volpara now operates ... Gleamer is expanding from its core focus in AI for musculoskeletal clinical applications into new clinical areas. We talked to ... Mosaic Clinical Technologies made its debut at as the AI division of Riverain Technologies develops AI-based solutions for analyzing thoracic CT scans, such as its ClearRead CT CAC solution for ... New developments in photon-counting CT are the focus of this New developments in imaging IT solutions are being launched at by Hyland. We talked to Hyland's Michael Campbell ...
We talked to Amanda Boone and Jacob Agris, MD, PhD, of ConcertAI at about the company's advanced visualization ... We talked to Merge Chief Medical Officer Raj Chopra, MD, and Stacy Sand of Aidoc about a new alliance between the companies ... We talked to Tim Joseph of Canon Medical Systems USA about what the company is highlighting in new MRI technology at ... Ikonopedia provides mammography reporting software to breast imaging centers, and we caught up with CEO and President ... While at , we had a chance to catch up with Steve Rankin, Chief Strategy Officer of Enlitic. Enlitic helps health systems ... We talked to Tim Glebinski and Bland Lee of Siemens Healthineers about new X-ray imaging technologies like the company's ...
We talked to DeepHealth executives Kees Wesdorp and Sham Sokka about the company's AI and imaging IT solutions, ... Harrison.ai is launching a new Harrison Open Platform for AI orchestration at this week's . We talked to company ... We talked to Maher Elhihi and Michelle Carter of Mindray at about new ultrasound solutions the company is introducing ... Imagion Biosystems is developing a new class of MRI contrast agents targeted at HER2+ breast cancer and other applications.
